Serena Nath is an IPilogue Writer and a 2L JD candidate at Osgoode Hall Law School. Controversy and uncertainty in the field of patent eligibility have resulted in decade-long fights…
Tag: biotechnology
Easy, Breezy, Bioprintable: 3D Printing in the Cosmetics Industry
Emily Xiang is an IPilogue Writer, President of the Intellectual Property Society of Osgoode, and a 2L JD candidate at Osgoode Hall Law School. What is Bioprinting? Bioprinting…
in Access to Medicines, Commercialization, Design, Development, IP, Patentability, Patents, Pharmaceutical Drugs, Uncategorized0by Editor
2529
What Makes It My Molecule: A Look at Professor Ronald Pearlman’s Genome Editing Work
This past November, Professor Ronald E. Pearlman from York University’s Department of Biology gave a talk [1] at Osgoode Hall Law School to discuss the potential of the innovative CRISPR…
More Money, More Problems: The Science, the Law, and the Fight over CRISPR Patents
From Lab Bench to Court Bench: The Science, the Law, and the CRISPR Patent Dispute Whenever a new technology has the potential to be ground-breaking and extremely valuable, there are…
Isolated Genes Are None Of Your Business! – SCOTUS Decides Myriad
On June 13, 2013, the U.S. Supreme Court rendered a decision which ruled against the patenting of isolated DNA sequences in their natural form in the now infamous case involving Myriad Genetics, Inc.…